Viewing Study NCT03134118


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-03-13 @ 2:55 AM
Study NCT ID: NCT03134118
Status: UNKNOWN
Last Update Posted: 2023-02-21
First Post: 2017-04-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module